Skip to content

Evaluation of the Efficacy of Panax Ginseng on Lipid Metabolism in Men and the Relationship With Sports Practice.

Evaluation of the Efficacy of Panax Ginseng on Lipid Metabolism in Men and the Relationship With Sports Practice.

Status
Completed
Phases
Early Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03888196
Acronym
GinsengRun
Enrollment
40
Registered
2019-03-25
Start date
2016-09-01
Completion date
2019-01-15
Last updated
2019-05-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sports Physical Therapy

Keywords

Panax, Lipid Metabolism, Sport Performance, Running, Ginseng

Brief summary

Panax Ginseng (P ginseng), C.A. Meyer, Red, Chinese or Korean ginseng is a plant from eastern Asia and is one of the most widely used herbal products in the world. P ginseng has been been used for many years for different medical therapies. Previous studies have demonstrate that P. ginseng root extract supplementation may promote fat oxidation, increase hepatic glycogen levels and produce a glycogen-sparing and antifatigue effect during exercise in swimming rats. Notwithstanding, although there is some evidence of P. ginseng effects in humans, no evidence has been obtained respect to its supplementation in human sport performance. The aim of this study is to assess the effect of P ginseng extract supplementation on the lipid metabolism and sport performance in male endurance runners. For this purpose, the effect of supplementation for 2 weeks of 500 mg/day of P. ginseng will be evaluated in a sub-maximal physical stress test. Variables of lipid metabolism, energy consumption, fatigue, and endurance will be determined.

Interventions

DIETARY_SUPPLEMENTPanax Ginseng Supplementation

500 mg/day of Panax Ginseng

DIETARY_SUPPLEMENTPlacebo Supplementation

500 mg/day of Cellulose

Sponsors

Universitat de Lleida
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
MALE
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Athletic men of aerobic type, who participate in a supervised training as a previous step to the accomplishment of competitions * Which their age is older than 18 years * Training superior or equal to 3 days per week and that these workouts are stable during the intervention.

Exclusion criteria

* Athletes with high blood pressure, with pharmacological treatment for hypercholesterolemia, diabetes, any psychiatric illness * Athletes who practice sports without having the objective of increasing sports performance * Athletes who use some type of ergogenic sport supplementation looking to optimize any aspect related to the sport.

Design outcomes

Primary

MeasureTime frameDescription
Change from baseline plasmatic Total Lipids at 2 weeks2 weeksTotal Lipids in the plasma are measured in mg / dL
Change from baseline plasmatic Triglycerides at 2 weeks2 weeksTriglycerides in the plasma are measured in mg / dL
Change from baseline Respiratory Exchange Rate at 2 weeks2 weeksTo quantify the amount of Oxygen consumed and the amount of carbon dioxide produced. (mL/Kg/Min)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026